Genworth Financial Inc (GNW) 2.70 $GNW Insurance Q2

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Genworth Financial Inc (GNW) 2.70 $GNW

Insurance Q2 Earnings Aug 2 Lineup: AIG, GNW, Y, AFG, MKL
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 9:20AM CDT
About 80% of the companies in the Finance sector have eported their results. Total earnings are down 4.2% while revenues have increased 1.1%.
AFG: 72.77 (+0.01), AIG: 54.04 (-0.17), Y: 536.81 (-6.76), GNW: 2.70 (-0.10), MKL: 943.59 (-7.67)

Next Resistance Level for Genworth Financial (GNW) is $2.93
Comtex SmarTrend(R) - Mon Aug 01, 8:39AM CDT
Shares of Genworth Financial (NYSE:GNW) have bullishly opened above the pivot of $2.82 today and have reached the first resistance level of $2.90. Investors may be interested in a cross of the next upside pivot targets of $2.93 and $3.04.
GNW: 2.70 (-0.10)

Genworth Financial (GNW) Q2 Earnings: What's in Store?
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 7:38AM CDT
Genworth Financial, Inc. (GNW) is set to report second-quarter 2016 results on Aug 2, after the market closes.
MFC: 13.38 (-0.04), SLF: 32.37 (-0.26), ALL: 68.05 (-0.34), GNW: 2.70 (-0.10)

Life Insurance Stocks Under Review -- Genworth Financial, MetLife, ING Groep, and Lincoln National
PR Newswire - Thu Jul 28, 6:30AM CDT
The Life Insurance space is taking massive steps toward transformation as alternative market players emerge and consumer confidence deteriorates. Stock-Callers.com takes a look at this morning's picks and see how they have fared in recent weeks despite the headwinds: Genworth Financial Inc. (NYSE: GNW), MetLife Inc. (NYSE: MET), ING Groep N.V. (NYSE: ING), and Lincoln National Corp. (NYSE: LNC). Learn more about these stocks by accessing their freenotes at:
IND: 26.21 (-0.03), MET: 42.12 (-0.43), ING: 10.53 (-0.39), LNC: 42.57 (-0.70), GNW: 2.70 (-0.10)

Genworth: Mortgage Insurance Solid, Investment Result Weak
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 9:20AM CDT
On Jul 13, 2016, we issued an updated research report on Genworth Financial, Inc. (GNW).
MFC: 13.38 (-0.04), GWGH: 6.75 (+0.06), GNW: 2.70 (-0.10), UAM: 7.46 (-0.14)

Genworth Financial (GNW) Crosses Pivot Point Resistance at $2.63
Comtex SmarTrend(R) - Mon Jul 11, 8:37AM CDT
Shares of Genworth Financial (NYSE:GNW) have bullishly opened above the pivot of $2.57 today and have reached the first resistance level of $2.63. Analysts will be watching for a cross of the next upside pivot targets of $2.68 and $2.79.
GNW: 2.70 (-0.10)

Genworth Survey: Surging Demand, Tighter Inventory, Create New Opportunities, Risks in Mortgage Lending
PR Newswire - Tue Jun 21, 6:00AM CDT
Genworth Mortgage Insurance ("Genworth" , a subsidiary of Genworth Financial, Inc. (NYSE: GNW), today released results from its study of industry executives conducted at the 2016 Mortgage Bankers Association Secondary Conference in New York City. Key findings showed that, when forecasting existing home sales, 78 percent of respondents expect first-time homebuyer market share to either continue at current levels or increase by at least three percentage points. This surge in new purchasers has driven demand, leading to tighter inventory.
GNW: 2.70 (-0.10)

Genworth: Growth Prospects Bright, Low Interest Rates a Drag
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 9:18AM CDT
On Jun 14, 2016, we issued an updated research report on Genworth Financial, Inc. (GNW).
HIIQ: 3.94 (-0.02), MFC: 13.38 (-0.04), GWGH: 6.75 (+0.06), GNW: 2.70 (-0.10)

Genworth Financial (GNW) Crosses Pivot Point Support at $3.57
Comtex SmarTrend(R) - Thu Jun 09, 9:12AM CDT
Shares of Genworth Financial (NYSE:GNW) have bearishly opened below the pivot of $3.67 today and have reached the first support level of $3.57. Analysts will be watching for a cross of the next downside pivot targets of $3.51 and $3.35.
GNW: 2.70 (-0.10)

Next Resistance Level for Genworth Financial (GNW) is $3.78
Comtex SmarTrend(R) - Tue May 31, 9:24AM CDT
Genworth Financial (NYSE:GNW) has opened bullishly above the pivot of $3.64 today and has reached the first level of resistance at $3.73. Investors may be interested in a cross of the next upside pivot targets of $3.78 and $3.92.
GNW: 2.70 (-0.10)

Genworth Canada DBRS Ratings Update
CNW Group - Tue May 17, 7:19PM CDT
DBRS confirms the rating for Genworth Financial Mortgage Insurance Company Canada at AA and revises the rating for Genworth MI Canada Inc. to A (high)
MIC.TO: 34.08 (-0.79), GNW: 2.70 (-0.10)

Sun Life Financial (SLF) Q1 Earnings Improve, Dividend Up
Zacks Equity Research - Zacks Investment Research - Wed May 11, 9:14AM CDT
Sun Life Financial Inc. (SLF) reported first-quarter 2016 operating net income of $409 million (C$531 million), up 19.1% year over year.
TMK: 60.61 (-0.68), SLF: 32.37 (-0.26), GNW: 2.70 (-0.10), RGA: 97.78 (-0.29)

Genworth 2016 Annual Cost of Care Study: Costs Continue to Rise, Particularly for Services in Home
PR Newswire - Tue May 10, 8:03AM CDT
According to the Genworth 2016 Cost of Care Study, the cost of receiving care continues to rise sharply year over year, especially for services in the home, where the vast majority of Americans receive long term care and for a longer period of time than facilities.[1]
GNW: 2.70 (-0.10)

AmTrust Financial Services, Inc. Completes Purchase of Genworth Financial Mortgage Insurance Ltd.
GlobeNewswire - Mon May 09, 3:17PM CDT
AmTrust Financial Services, Inc. (Nasdaq:AFSI) (the "Company" or "AmTrust" today announced that it has completed the acquisition of Genworth Financial Mortgage Insurance Ltd. ("GFMI" from Genworth Financial, Inc. (NYSE:GNW), for approximately $55 million in cash. As of December 31, 2015, GFMI's tangible book value was approximately $150 million. Based in the U.K., GFMI is a well-known organization in the European mortgage insurance market, currently providing products in the U.K., Finland, Italy and Germany.
AFSI: 24.89 (+0.58), GNW: 2.70 (-0.10)

Genworth Announces Completion Of European Mortgage Insurance Business Sale
PR Newswire - Mon May 09, 3:15PM CDT
Genworth Financial, Inc. (NYSE:GNW) announced that Genworth Mortgage Insurance Corporation (GMICO), a wholly owned indirect subsidiary of the company, has completed the sale of its European mortgage insurance business to AmTrust Financial Services, Inc. Net proceeds of approximately $50 million will provide additional capital to GMICO. This transaction represents another action toward simplifying Genworth's businesses.
AFSI: 24.89 (+0.58), GNW: 2.70 (-0.10)

Broadcast and Presentation Information For Genworth Financial 2016 Annual Meeting Of Stockholders
PR Newswire - Thu May 05, 3:10PM CDT
Genworth Financial, Inc. (NYSE: GNW) will offer a listen-only broadcast of its 2016 Annual Meeting of Stockholders to be held at 9:00 a.m. (ET), May 12, 2016. The accompanying slide presentation materials will be posted to the company's website, http://investor.genworth.com, by 8:00 a.m. on May 12, 2016.
GNW: 2.70 (-0.10)

American International (AIG) Q1 Earnings Miss, Plunge Y/Y
Zacks Equity Research - Zacks Investment Research - Tue May 03, 9:19AM CDT
American International Group Inc. (AIG) reported first-quarter 2016 operating income of 65 cents per share that missed the Zacks Consensus Estimate of 99 cents by 34.3%. Earnings also plunged 46.7% year on year.
CNO: 15.60 (-0.37), AIG: 54.04 (-0.17), MTG: 7.11 (-0.15), GNW: 2.70 (-0.10)

Genworth Financial Set to Possibly Pullback After Yesterday's Rally of 14.72%
Comtex SmarTrend(R) - Mon May 02, 2:30PM CDT
Genworth Financial (NYSE:GNW) traded in a range yesterday that spanned from a low of $3.54 to a high of $4.06. Yesterday, the shares gained 14.7%, which took the trading range above the 3-day high of $3.48 on volume of 14.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
GNW: 2.70 (-0.10)

SmarTrend Watching for Potential Pullback in Shares of Genworth Financial After 14.72% Gain
Comtex SmarTrend(R) - Mon May 02, 2:28PM CDT
Genworth Financial (NYSE:GNW) traded in a range yesterday that spanned from a low of $3.54 to a high of $4.06. Yesterday, the shares gained 14.7%, which took the trading range above the 3-day high of $3.48 on volume of 14.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
GNW: 2.70 (-0.10)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vipshop Prepares for Q3 Financial Results Release

Updated Category News Views 60

Countdown to Vipshop's Third Quarter Results November 24th might just be another day on the calendar for some, but for those of us keeping tabs on the markets, it's a make-or-break moment for Vipshop Holdings Limited. The off-price retail titan from China, trailing under the ticker NYSE:VIPS, is gearing up to swing the doors wide open on its third-quarter financial...

Continue Reading
Orangetheory Adds NASM Training for Coaching Edge

Updated Category News Views 19

A Shift in Coaching Standards Ever seen a fitness brand tilt towards a change so fast it leaves you slack-jawed? Well, here we go with Orangetheory Fitness pushing its chips all in with NASM-certified coaches geared for the GLP-1 era. A bold move? Sure, but they aim to become trendsetters instead of just another player in the fitness game. The Impact of NASM Certification...

Continue Reading
HearUSA Expands Access with AI-Powered Hearing Aids

Updated Category News Views 24

AI Revolution in Hearing Care Look, the hearing aid industry isn't known for headlines that grab you by the throat, but HearUSA just tossed a proverbial grenade into the scene with Widex Allure AI RIC. This is more than a slight tweak in hearing tech—it's a game-changer. We're talking about on-demand AI noise management blended with Widex's renowned natural sound. It's...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 139

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
YYForce's Strategic Play: Robotics and AI Expansion

Updated Category News Views 11

Innovation Meets Pragmatism at YYForce There's a new bout of excitement brewing over at YYForce Inc. (NASDAQ: YFOR), if the latest announcements are anything to go by. The Singapore-based AI-enabled workforce dynamo is laying out priorities like a general plotting a campaign—pragmatic, strategic, and with a keen eye on the bottom line. Aiming for a Technological Edge In...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 150

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 254

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 94

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Asia-Pacific Miracle: New Economic Chapter Unfolds

Updated Category News Views 31

A Fresh Breeze in Asia-Pacific's Sails You ever look around and realize everything's about to change—again? That's Asia-Pacific right now. We're staring down the barrel of a new chapter in what folks are calling the "Asia-Pacific miracle." The text from China Daily paints a picture of a region gearing up to crank the cooperation dial even higher. And where's this...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 343

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

BitGo Faces Securities Fraud Suit Amid Investor Losses

Updated Category News Views 69

BitGo's Legal Woes: A Deep Dive into the Allegations A lawsuit can shake up a company's foundations, and BitGo Holdings, Inc. (NYSE: BTGO) is feeling the heat right now. The focus of this busy investor morning isn’t some penny stock drama; we're talking about players in the digital asset game accused of pulling the wool over investors' eyes. Slap on those reading...

Continue Reading
Investors Alert: Deadline Approaches in Match Group Lawsuit

Updated Category News Views 141

Important Deadline Approaching for Match Group Investors Recently, there has been a notable reminder for investors concerning a class action lawsuit involving Match Group, Inc. (NASDAQ: MTCH). The law firm Glancy Prongay & Murray LLP has highlighted that all individuals who purchased shares in Match Group during the specified period should be aware of the upcoming...

Continue Reading
Leadership Transition at Coloplast A/S: New Era Begins

Updated Category News Views 937

Coloplast A/S Announces Leadership Change In a significant shift for Coloplast A/S, CEO Kristian Villumsen has officially stepped down. Today marks the start of a new chapter as the Board of Directors mobilizes Lars Rasmussen to serve as interim CEO while the search for a permanent replacement is conducted. Strategic Shift for the Future This change comes at an opportune...

Continue Reading
Johnson & Johnson's Strong Q3 Results Amid Market Declines

Updated Category News Views 109

Market Overview On a day marked by declining values, U.S. stocks experienced a noticeable downturn. The Nasdaq Composite index saw a drop of around 150 points, indicating a challenging market environment. As trading progressed, the Dow Jones Industrial Average slipped slightly, and the S&P 500 also followed suit, showing varied performance across sectors. Sector...

Continue Reading
Moroccanoil Expands Product Line at Ulta Beauty Nationwide

Updated Category News Views 204

Moroccanoil Expands Product Line at Ulta Beauty Nationwide Moroccanoil is thrilled to announce an exciting partnership with Ulta Beauty, the premier beauty retailer in the nation. This significant expansion reaffirms Moroccanoil's commitment to delivering high-quality beauty products to a wider audience while honoring its legacy rooted in the salon community. Launching at...

Continue Reading